Guardian Pharmacy Services, Inc.
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.35% | 5.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.35% | 5.35% | |||
| Cost of Revenue | -16.61% | 3.11% | |||
| Gross Profit | -10.75% | 14.43% | |||
| SG&A Expenses | 10.56% | -13.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.85% | 0.48% | |||
| Operating Income | -40.97% | 109.28% | |||
| Income Before Tax | -41.18% | 86.99% | |||
| Income Tax Expenses | -51.71% | 39.73% | |||
| Earnings from Continuing Operations | -36.31% | 121.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 27.19% | -252.00% | |||
| Net Income | -36.46% | 113.11% | |||
| EBIT | -40.97% | 109.28% | |||
| EBITDA | -34.67% | 80.79% | |||
| EPS Basic | -68.22% | 109.11% | |||
| Normalized Basic EPS | -70.00% | 96.71% | |||
| EPS Diluted | -68.26% | 112.47% | |||
| Normalized Diluted EPS | -70.03% | 99.88% | |||
| Average Basic Shares Outstanding | 100.00% | 1.93% | |||
| Average Diluted Shares Outstanding | 100.23% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||